Andros Pharmaceuticals Co., Ltd. (6917)
Market Closed
11 Aug, 05:30
TWSE TWSE Primary NT$
32. 05
-0.15
-0.4658%
NT$
718.59M Market Cap
- P/E Ratio
- Div Yield
129,906 Volume
- Eps
NT$ 32.2
Previous Close Want to track 6917 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Andros Pharmaceuticals Co., Ltd. (6917) Statistics
Valuation metrics
Market Cap 718.59M
Enterprise value 1.73B
Trailing P/E (ttm) -27.76
Forward P/E -
PEG ratio -0.28
Price/Sales (ttm) 317.89
Price/Book (mrq) 2.89
Enterprise Value/Revenue 311.24
Enterprise Value/EBITDA -25.07
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 159.41K
Average volume (90 days) 302.85K
Price summary
52-Week low 16.95
52-Week high 45.95
Beta -
50-Day moving average 32.06
200-Day moving average 29.52
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 53:50
Last split Date 18 Jul 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -9.69%
Operating margin -13.63%
Operational effectiveness
Return on assets -0.1%
Return on equity -0.12%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.12
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.16
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 8
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 13.97%
Book value per share (mrq) 11.14
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
